The
genitourinary drugs market covers drugs that are used in the treatment of
diseases such as urinary tract infections, male reproductive diseases, voiding
diseases, female reproductive diseases, glomerular disorders, urinary calculi,
cystic kidney disease, renovascular diseases, benign prostate diseases, and
other related diseases.
Read the report at
The major
reason why the global genitourinary drugs market will increase from $63 billion
in 2017 to close to $82 billion by 2021 is growth of genitourinary disorders
like chronic kidney disease CKD and the number of pipeline drugs.
In the
report, the global genitourinary drugs market is divided into eight segments
namely, hormonal contraceptives, drugs for hormonal replacement therapy, drugs
for infections and others, drugs for benign prostatic hypertrophy, drugs for
erectile dysfunction, drugs for urinary incontinence and overactive bladder,
drugs for infertility, and diuretics. While the first and the second segments
account for nearly three-fifth of the market share, the remaining share is
attributed to the other six segments.
Download a sample of the report at
The USA
was the largest country in the genitourinary drugs market in 2017, accounting
for around 30% of the market share. This can be attributed to the high
prevalence of urinary diseases like chronic kidney diseases, erectile
dysfunction and infertility in the country. Moreover, public awareness and
expenditure on health care is high in the USA. China and Italy followed the USA
as the next largest countries in the market.
The
genitourinary drugs market is fragmented with a number of large and small drugs
organizations. The top five competitors in the market made up 14% of the total
market in 2017. Daiichi Sankyo Company, Limited was the largest competitor of
the market, followed by Pfizer Inc. and Bayer AG. Daiichi Sankyo Company is
involved in the research, development and marketing of pharmaceutical products
for osteoporosis, ulcer treatment, alzheimer’s disease, anti-influenza
treatment, hypertension and diabetes. The company is headquartered in Tokyo,
Japan and employs 14,670 people.
About
The Business Research Company.
The
Business Research Company is a Business Intelligence Company which excels in
company, market and consumer research. It has
offices in the UK, the US and India and a network of trained researchers in 15
countries globally.
Contact
Information.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
No comments:
Post a Comment